Inside Precision Medicine January 5, 2024
Remote diagnostics company Nanowear announced on Thursday that its nanotechnology-enabled wearable remote monitoring device and its SimpleSense platform received FDA 510(k) clearance as a continuous blood pressure monitor. SimpleSense-BP is a novel Softwear-as-a-Medical Device (SaMD) platform that combines the company’s proprietary cloth-embedded nanotechnology sensors and its artificial intelligence (AI) and machine learning (ML) to provide clinical-grade decision support as a cardiopulmonary clinical decision support tool.
“This FDA clearance represents an exciting and differentiating moment for Nanowear. Accelerated by the pandemic, the market has been eagerly searching for reliable, clinical-grade wearable, and data service solutions that find product market fit with the following three attributes: at-home, utilizing AI, and a proven team that executes,” says Venk Varadan, CEO and co-founder of...
Today's Sponsors
Today's Sponsor